[go: up one dir, main page]

NO20003050D0 - Metode for Õ administrere monomere insulinanaloger - Google Patents

Metode for Õ administrere monomere insulinanaloger

Info

Publication number
NO20003050D0
NO20003050D0 NO20003050A NO20003050A NO20003050D0 NO 20003050 D0 NO20003050 D0 NO 20003050D0 NO 20003050 A NO20003050 A NO 20003050A NO 20003050 A NO20003050 A NO 20003050A NO 20003050 D0 NO20003050 D0 NO 20003050D0
Authority
NO
Norway
Prior art keywords
insulin analogues
monomeric insulin
administering monomeric
administering
analogues
Prior art date
Application number
NO20003050A
Other languages
English (en)
Norwegian (no)
Other versions
NO20003050L (no
Inventor
Richard Dennis Dimarchi
Roger Garrick Harrison
Ronald Keith Wolff
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20003050L publication Critical patent/NO20003050L/no
Publication of NO20003050D0 publication Critical patent/NO20003050D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
NO20003050A 1998-01-08 2000-06-14 Metode for Õ administrere monomere insulinanaloger NO20003050D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7075298P 1998-01-08 1998-01-08
PCT/US1999/000324 WO1999034816A1 (fr) 1998-01-08 1999-01-07 Methode d'administration d'analogues d'insuline monomere

Publications (2)

Publication Number Publication Date
NO20003050L NO20003050L (no) 2000-06-14
NO20003050D0 true NO20003050D0 (no) 2000-06-14

Family

ID=22097181

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20003051A NO20003051D0 (no) 1998-01-08 2000-06-14 Metode for administrering av AspB28-humant insulin
NO20003050A NO20003050D0 (no) 1998-01-08 2000-06-14 Metode for Õ administrere monomere insulinanaloger

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20003051A NO20003051D0 (no) 1998-01-08 2000-06-14 Metode for administrering av AspB28-humant insulin

Country Status (16)

Country Link
US (2) US20010053761A1 (fr)
EP (2) EP0951910A3 (fr)
JP (2) JP2002500192A (fr)
KR (2) KR20010033940A (fr)
CN (2) CN1287492A (fr)
AU (2) AU754707B2 (fr)
BR (2) BR9906813A (fr)
CA (2) CA2317739A1 (fr)
EA (2) EA200000747A1 (fr)
HU (2) HUP0101293A3 (fr)
IL (2) IL137150A0 (fr)
NO (2) NO20003051D0 (fr)
PL (2) PL342745A1 (fr)
TR (2) TR200001891T2 (fr)
WO (2) WO1999034816A1 (fr)
ZA (2) ZA99105B (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6131567A (en) * 1993-01-29 2000-10-17 Aradigm Corporation Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
US20060171899A1 (en) * 1998-12-10 2006-08-03 Akwete Adjei Water-stabilized aerosol formulation system and method of making
US6858199B1 (en) * 2000-06-09 2005-02-22 Advanced Inhalation Research, Inc. High efficient delivery of a large therapeutic mass aerosol
AU5453300A (en) * 1999-06-29 2001-01-31 Eli Lilly And Company Insulin crystals for pulmonary administration
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
DE60138641D1 (de) 2000-10-27 2009-06-18 Baxter Healthcare Sa Herstellung von mikrokügelchen
EP1944016A1 (fr) 2001-08-16 2008-07-16 Baxter International Inc. Formules de microparticules propulsives
WO2003015750A1 (fr) * 2001-08-16 2003-02-27 Baxter International, Inc. Preparations de microparticules a base d'un agent propulseur
JP2005514188A (ja) * 2001-12-07 2005-05-19 エイフェル テクノロジーズ リミテッド 小粒子の合成
JP2005539208A (ja) * 2001-12-21 2005-12-22 スミスクライン ビーチャム コーポレーション グルコース産生を変化させるための組成物および方法
US7118010B2 (en) 2002-05-10 2006-10-10 Oriel Therapeutics, Inc. Apparatus, systems and related methods for dispensing and /or evaluating dry powders
US7677411B2 (en) * 2002-05-10 2010-03-16 Oriel Therapeutics, Inc. Apparatus, systems and related methods for processing, dispensing and/or evaluatingl dry powders
US6889690B2 (en) 2002-05-10 2005-05-10 Oriel Therapeutics, Inc. Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages
US6985798B2 (en) * 2002-05-10 2006-01-10 Oriel Therapeutics, Inc. Dry powder dose filling systems and related methods
EP1534366B1 (fr) 2002-06-27 2014-01-08 Oriel Therapeutics, Inc. Systemes de remplissage de dose de poudre seche, et procedes connexes
US7451761B2 (en) 2003-10-27 2008-11-18 Oriel Therapeutics, Inc. Dry powder inhalers, related blister package indexing and opening mechanisms, and associated methods of dispensing dry powder substances
US7377277B2 (en) 2003-10-27 2008-05-27 Oriel Therapeutics, Inc. Blister packages with frames and associated methods of fabricating dry powder drug containment systems
WO2005044173A1 (fr) 2003-10-27 2005-05-19 Oriel Therapeutics, Inc. Emballages-coque et procedes associes de fabrication de systemes de confinement de medicaments en poudre seche
WO2005065756A2 (fr) 2003-12-30 2005-07-21 Oriel Therapeutics, Inc. Nebuliseurs de poudre seche et procedes associes de dispersion de poudres seches
US7624733B2 (en) 2004-02-09 2009-12-01 Oriel Therapeutics, Inc. Inhalers with extendable/retractable forward member and associated methods of dispensing inhalant substances
CA2616997C (fr) * 2004-09-13 2014-12-23 Oriel Therapeutics, Inc. Inhalateurs a poudre seche d'inhibition d'agregat, dispositifs et procedes associes
WO2007024953A1 (fr) * 2005-08-25 2007-03-01 Oriel Therapeutics, Inc. Systemes contenant un medicament avec sticks et kits associes, inhalateurs a poudre anhydre, et procedes correspondants
US7987845B2 (en) 2006-01-31 2011-08-02 Oriel Therapeutics, Inc. Dry powder inhalers having spiral travel paths, unit dose microcartridges with dry powder, related devices and methods
EP2060268A1 (fr) * 2007-11-15 2009-05-20 Novo Nordisk A/S Compositions pharmaceutiques pour distribution pulmonaire ou nasale de peptides
CA2732840C (fr) 2008-09-26 2016-07-05 Oriel Therapeutics, Inc. Inhalateurs de poudre seche pourvus d'organes de percage doubles et dispositifs et procedes associes
CN102159270B (zh) 2008-09-26 2014-07-02 奥里尔治疗公司 一种带有具有气道盘沟槽的气道盘的吸入器和相关的气道盘和方法
WO2010036355A2 (fr) 2008-09-26 2010-04-01 Oriel Therapeutics, Inc. Mécanismes d’inhalateurs avec éperons sollicités radialement et procédés associés
WO2010039200A2 (fr) * 2008-09-30 2010-04-08 Oriel Therapeutics, Inc. Inhalateur de poudre sèche à bandes sans fin et perceurs en interaction, et procédés associés
WO2010039201A2 (fr) * 2008-09-30 2010-04-08 Oriel Therapeutics, Inc. Inhalateurs de poudre sèche comportant un compartiment de désagglomération à surface multifacettes, et dispositifs et procédés associés
WO2010039202A2 (fr) * 2008-10-01 2010-04-08 Oriel Therapeutics, Inc. Inhalateurs de poudre sèche à mécanismes de percement rotatifs, et dispositifs et procédés associés
JP5341532B2 (ja) * 2009-01-19 2013-11-13 第一電子工業株式会社 １対の誤嵌合防止キー及び該キーを用いた電気コネクタ
CN101912600B (zh) * 2010-01-11 2014-01-29 杨国汉 改善胰岛素在溶液中稳定性的方法
WO2011080747A2 (fr) 2010-01-27 2011-07-07 Aespira Ltd. Inhalateur de poudre sèche
USD635246S1 (en) 2010-03-26 2011-03-29 Oriel Therapeutics, Inc. Dose disk for dry powder inhalers
USD641076S1 (en) 2010-03-26 2011-07-05 Oriel Therapeutics, Inc. Dry powder inhaler
US11491288B2 (en) 2014-01-08 2022-11-08 Seroton, Inc. Dispenser for dry-powder inhalation devices
US10238820B2 (en) 2014-01-08 2019-03-26 Seroton, Inc. Dry-powder inhalation device
WO2024100652A1 (fr) 2022-11-07 2024-05-16 Kritzman Kadron Amnon Inhalateur de poudre sèche haute performance

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK179286D0 (da) * 1986-04-18 1986-04-18 Nordisk Gentofte Insulinpraeparat
NZ232375A (en) * 1989-02-09 1992-04-28 Lilly Co Eli Insulin analogues modified at b29
US5230884A (en) * 1990-09-11 1993-07-27 University Of Wales College Of Cardiff Aerosol formulations including proteins and peptides solubilized in reverse micelles and process for making the aerosol formulations
US6131567A (en) * 1993-01-29 2000-10-17 Aradigm Corporation Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
DK72793D0 (da) * 1993-06-21 1993-06-21 Novo Nordisk As Nyt produkt
WO1995000550A1 (fr) * 1993-06-21 1995-01-05 Novo Nordisk A/S Cristaux d'insuline asp?b28¿
TW402506B (en) * 1993-06-24 2000-08-21 Astra Ab Therapeutic preparation for inhalation
US5451569A (en) * 1994-04-19 1995-09-19 Hong Kong University Of Science And Technology R & D Corporation Limited Pulmonary drug delivery system
US5461031A (en) * 1994-06-16 1995-10-24 Eli Lilly And Company Monomeric insulin analog formulations
US5547929A (en) * 1994-09-12 1996-08-20 Eli Lilly And Company Insulin analog formulations
AR002976A1 (es) * 1995-03-31 1998-05-27 Lilly Co Eli Formulaciones farmaceuticas parenterales de efecto prolongado de insulina; cristales de dichos analogos aplicables en dichas formulaciones yprocedimiento de las formulaciones mencionadas
CA2223272A1 (fr) * 1995-05-05 1996-11-07 Ronald Eugene Chance Insuline monocatenaire a bioactivite elevee

Also Published As

Publication number Publication date
HUP0101293A3 (en) 2001-12-28
AU2312299A (en) 1999-07-26
US20010053761A1 (en) 2001-12-20
NO20003050L (no) 2000-06-14
AU747619B2 (en) 2002-05-16
WO1999034816A1 (fr) 1999-07-15
AU2107399A (en) 1999-07-26
EP0951910A3 (fr) 2002-06-19
EP0951910A2 (fr) 1999-10-27
HUP0100391A3 (en) 2001-12-28
WO1999034815A1 (fr) 1999-07-15
KR20010033941A (ko) 2001-04-25
CA2317733A1 (fr) 1999-07-15
NO20003051L (no) 2000-06-14
PL341592A1 (en) 2001-04-23
ZA99105B (en) 2000-07-07
US20010007853A1 (en) 2001-07-12
NO20003051D0 (no) 2000-06-14
CN1195543C (zh) 2005-04-06
JP2002500193A (ja) 2002-01-08
IL137150A0 (en) 2001-07-24
EA200000747A1 (ru) 2000-12-25
EP0951911A3 (fr) 2002-06-19
IL137105A0 (en) 2001-06-14
ZA99104B (en) 2000-07-07
BR9906813A (pt) 2001-03-20
CA2317739A1 (fr) 1999-07-15
CN1287492A (zh) 2001-03-14
EP0951911A2 (fr) 1999-10-27
HUP0100391A2 (hu) 2001-08-28
BR9906796A (pt) 2000-11-14
JP2002500192A (ja) 2002-01-08
TR200001891T2 (tr) 2000-11-21
AU754707B2 (en) 2002-11-21
TR200001892T2 (tr) 2000-11-21
KR20010033940A (ko) 2001-04-25
EA200000748A1 (ru) 2000-12-25
HUP0101293A2 (hu) 2001-08-28
PL342745A1 (en) 2001-07-02
CN1287491A (zh) 2001-03-14

Similar Documents

Publication Publication Date Title
NO20003050D0 (no) Metode for Õ administrere monomere insulinanaloger
NO20010982D0 (no) FremgangsmÕte for Õ administrere insulinotropiske peptider
ATE237635T1 (de) Acylierte insulinanalogen
DE59909597D1 (de) Verfahren zur kontrolle der insulinmedikation
DE69826705D1 (de) Verfahren zur dermalen verabreichung von polypeptiden
DK1223997T3 (da) Medicinsk infusionssæt
DE69827328D1 (de) Vormontierte Spritze
DK0963211T3 (da) Hypodermisk injektionssystem
DE69829787D1 (de) Verbesserte Injektionsspritze
ZA989744B (en) Method for administering acylated insulin.
DE69829554D1 (de) Ovalgefortme herzkanüle
DE60011853D1 (de) Injektionsspritze
DE69827249D1 (de) Elektrochemisch angetriebene spritzenpumpe
DE69816443D1 (de) Sicherheitsspritze
DE69919784D1 (de) Spritze
ID28015A (id) Peningkatan stabilitas larutan injeksi
IT1279684B1 (it) Siringa per iniezioni ipodermiche.
ID20685A (id) Sediaan-sediaan farmasi silansetron yang distabilkan terhadap rasemisasi
NO20006320D0 (no) Cykliske somatostatin-analoger
NO981995D0 (no) Horisontalpumpesystem
DE69726820D1 (de) Spritzenpumpe
ID20665A (id) Metode pelarutan karet secara kontinyu
DE60033447D1 (de) Optisch reine Camptothecin-Analoge
FI981338L (fi) Menetelmä multikomponentti-alfa-interferonin valmistamiseksi
FR2749172B1 (fr) Seringue hypodermique

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application